SCHEMBL6948041

SCHEMBL6948041

N#Cc1c(OCC(F)(F)F)nc(NCCN2CCCC2)nc1N1CCc2ccccc2CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCC1 P33527 2/20 0.41
TRPV1 Q8NER1 1/20 0.41
KDM4E B2RXH2 9/20 0.37
ALDH1A1 P00352 8/20 0.37
GAA P10253 4/20 0.37
MAPT P10636 4/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
HTT P42858 2/20 0.37
HIF1A Q16665 2/20 0.37
POLB P06746 1/20 0.37
HPGD P15428 6/20 0.36
HSD17B10 Q99714 3/20 0.36
CASP1 P29466 1/20 0.36
CASP7 P55210 1/20 0.36
NPSR1 Q6W5P4 3/20 0.36
ALOX12 P18054 1/20 0.36
PIK3CD O00329 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6949377 0.92 MEN1 (0.42) KDM4EALDH1A1GAAMAPTMEN1
SCHEMBL6945704 0.88 GRIN2D (0.41) KDM4EALDH1A1GAAMAPTMEN1
SCHEMBL6952835 0.87 KDM4E (0.43) KDM4EALDH1A1GAAMAPTMEN1
SCHEMBL6945718 0.86 ALDH1A1 (0.40) KDM4EALDH1A1GAAMAPTMEN1
SCHEMBL6951267 0.84 ALDH1A1 (0.40) TRPV1KDM4EALDH1A1GAAMAPT
SCHEMBL6955488 0.83 AURKA (0.38) TRPV1KDM4EALDH1A1MAPTMEN1
SCHEMBL6949140 0.83 PLK1 (0.39) KDM4EALDH1A1GAAMAPTMEN1
SCHEMBL6953994 0.82 GLA (0.41) KDM4EALDH1A1GAAMAPTKMT2A
SCHEMBL6947660 0.82 OGA (0.40) HRH1HRH4
SCHEMBL6952840 0.81 PIK3CD (0.38) KDM4EALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed